-

Ludi Inc.’s DocTime® Achieves HITRUST i1 Certification to Manage Data Protection & Mitigate Cybersecurity Threats

HITRUST certification confirms Ludi uses top security practices to protect sensitive information, setting a new standard in the provider compensation industry.

NASHVILLE, Tenn.--(BUSINESS WIRE)--Ludi, Inc., the leader in provider compensation solutions, today announced its pioneering DocTime® technology has earned certified status by HITRUST for information security.

HITRUST i1 Certification demonstrates that Ludi’s DocTime leverages a set of curated controls to protect against current and emerging threats. The HITRUST i1 Validated Assessment and Certification helps organizations address cybersecurity challenges and remain cyber resilient over time.

"Every day, healthcare organizations rely on us to streamline provider compensation and protect their data," said Danielle O’Rourke, CEO of Ludi. "Earning HITRUST i1 Certification is more than just a milestone—it’s a testament to our relentless commitment to security, accuracy, and the trust our clients place in us. In an era where compliance and data integrity are non-negotiable, we’re not just keeping up—we’re setting the standard for the provider compensation industry."

This certification emphasizes Ludi’s dedication to upholding the highest information security standards, aligning with best industry practices to safeguard sensitive healthcare data.

“HITRUST is continually innovating to find new and creative approaches to address information security challenges,” said Jeremy Huval, Chief Innovation Officer at HITRUST. “Ludi’s HITRUST i1 Certification reflects their commitment to adopting the gold standard in information risk management and cybersecurity.”

With this recognition, Ludi continues to lead the way in provider compensation, driving the industry to new standards. By constantly innovating and prioritizing data security and compliance, Ludi reaffirms its position as a trusted, long-term partner to healthcare organizations nationwide.

About Ludi
Ludi is the leader in provider compensation solutions, leveraging innovative technology and exceptional client support to streamline provider arrangements and payments for healthcare organizations nationwide. Ludi offers DocTime®, the most advanced and fully integrated compensation management solution in the industry. By marrying financial, performance, and quality data, DocTime addresses the complexities of provider compensation, helping healthcare organizations improve efficiency, reduce costs and compliance risk, measure physician contribution, and elevate provider satisfaction.

Contacts

Ludi media contact:
Jeff Hyman-Marshall, VP Marketing
Ludi, Inc.
JHyman-Marshall@Ludiinc.com

Ludi, Inc.


Release Versions

Contacts

Ludi media contact:
Jeff Hyman-Marshall, VP Marketing
Ludi, Inc.
JHyman-Marshall@Ludiinc.com

More News From Ludi, Inc.

Great Point Partners Named to Inc.’s 2025 List of Founder-Friendly Investors for Third Consecutive Year

GREENWICH, Conn.--(BUSINESS WIRE)--Great Point Partners, (“Great Point”) a Greenwich-based private investment firm focused exclusively on the health care industry, announced today that it was again recognized on Inc.’s Founder-Friendly Investors list. This list honors the private equity, venture capital, and debt firms with track records of successfully partnering with the founder-led businesses they invest in, while maintaining their entrepreneurial spirit. This marks the third consecutive yea...

Eutecma Announces Kevin Grogan as Chief Executive Officer to Lead Global Operations and Expansion

MANNHEIM, Germany & SPRINGFIELD, Ohio--(BUSINESS WIRE)--Eutecma (or “the Company”), a German-based developer of sustainable, modular, and reusable temperature controlled packaging solutions for pharmaceutical cold chain shipments, today announced the appointment of Kevin Grogan as Chief Executive Officer to lead the Company’s global operations and expansion. Mr. Grogan has nearly thirty years of industry expertise in pharmaceutical, healthcare and foodservice packaging solutions across North Am...

Spark Biomedical and Velentium Medical Strengthen Partnership Through Launch of New Femtech Wellness Product

HOUSTON--(BUSINESS WIRE)--Spark Biomedical and Velentium Medical, longtime partners in neuromodulation device development, today announced their partnership in the launch of OhmBody™, a division of Spark Biomedical pioneering a non-invasive wellness product intended to help reduce cramps and unhealthy amounts of menstrual blood loss, as well as “provide support for other disruptive effects of your period like fatigue, gastric discomfort, and emotional fluctuations while supporting balance from...
Back to Newsroom